Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
34 studies found for:    " August 20, 2008":" September 19, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" August 20, 2008":" September 19, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Affect Management Intervention for Early Adolescents Wtih Mental Health Problems
Condition: HIV Infections
Interventions: Behavioral: Affect Management;   Behavioral: General Health Promotion
2 Unknown  Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects
Condition: HIV Infections
Intervention: Drug: Raltegravir and Abacavir/Lamivudine
3 Completed An Affect Management Intervention for Juvenile Offenders
Condition: HIV Infections
Interventions: Behavioral: Affect Management;   Behavioral: General Health Promotion
4 Completed Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients
Condition: HIV Infections
Interventions: Drug: Kaletra + Isentress;   Drug: Atripla
5 Completed IMARA, Adapting SiHLE for Detained African American Adolescent Females
Condition: HIV Infections
Intervention: Behavioral: IMARA HIV Prevention Intervention
6 Completed
Has Results
Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women
Condition: HIV Infections
Intervention: Drug: Raltegravir
7 Completed Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia
Condition: HIV Infections
Intervention: Drug: Routine three-drug antiretroviral prophylaxis
8 Completed Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients
Condition: HIV Infections
Intervention: Drug: lopinavir/ritonavir and raltegravir
9 Completed Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine
Condition: HIV Infections
Intervention: Biological: Tat protein
10 Completed Effect of an Online Video-Based Intervention to Increase HIV Testing in Men Who Have Sex With Men in Peru
Condition: HIV Infections
Interventions: Device: HIV-testing motivational videos;   Device: Standard public health text
11 Completed
Has Results
BRAVO: Background Regimen of Raltegravir on Virologic Outcome
Condition: HIV Infections
Intervention: Drug: raltegravir
12 Completed
Has Results
Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
Condition: HIV Infections
Interventions: Drug: ATV/r;   Drug: DRV/r
13 Unknown  Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment
Condition: HIV Infections
Intervention: Drug: Raltegravir and Atazanavir
14 Completed Assessment of Cytokine Values in Serum and by RT-PCR in HIV-1 Individuals With and Without HAART
Condition: HIV Infections
Intervention:
15 Completed Community-based Evaluation of a Pilot PMTCT Project in Kafue District
Conditions: Death;   HIV Infection
Intervention: Other: Community-based Survey
16 Terminated
Has Results
A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071)
Condition: HIV
Interventions: Drug: Comparator: Raltegravir 400 mg b.i.d.;   Drug: Experimental: Raltegravir 800 mg q.d.;   Drug: TRUVADA™
17 Completed Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1265744 10 mg oral solution;   Drug: GSK1265744 5 mg tablet
18 Completed
Has Results
Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.
Conditions: HIV Infections;   HSV-2 Genital Herpes
Intervention: Drug: 3% SPL7013 Gel (VivaGel)
19 Terminated A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects
Conditions: HIV;   Tuberculosis
Interventions: Drug: lopinavir/ritonavir;   Drug: rifabutin
20 Completed
Has Results
Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment
Condition: HIV
Interventions: Drug: ritonavir;   Drug: darunavir;   Drug: emtricitabine [FTC]/tenofovir [TDF];   Drug: atazanavir

   Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.